Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19 Patients in the Intensive Care Unit: A Case-Control Study

MLA

Canbaz, Hayri, et al. “Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19 Patients in the Intensive Care Unit: A Case-Control Study.” Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology, vol. 39, no. 4, Dec. 2022, pp. 222–29. EBSCOhost, https://doi.org/10.4274/tjh.galenos.2022.2022.0103.

APA

Canbaz, H., İdiz, U. O., Cankar Dal, H., Kaçıroğlu, F., Taş, S., Çubukçu, H. C., Beştemir, A., Gülşen, M., Polat, İ. T., Laloğlu, A., Tör, İ. H., Akkurt, H. E., Ateş, U., Reisli, İ., Koç, E., İnkaya, A. Ç., Karakükçü, M., Ceylan, M., Haznedaroğlu, İ. C., & Akın, H. (2022). Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19 Patients in the Intensive Care Unit: A Case-Control Study. Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology, 39(4), 222–229. https://doi.org/10.4274/tjh.galenos.2022.2022.0103

Chicago

Canbaz, Hayri, Ufuk Oğuz İdiz, Hayriye Cankar Dal, Fatih Kaçıroğlu, Seher Taş, Hikmet Can Çubukçu, Attila Beştemir, et al. 2022. “Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19 Patients in the Intensive Care Unit: A Case-Control Study.” Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology 39 (4): 222–29. doi:10.4274/tjh.galenos.2022.2022.0103.